Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

RasGRP4 Inhibitors

RasGRP4 inhibitors represent a specific class of chemical compounds that have garnered attention in the realm of molecular biology and cellular signaling research. RasGRP4, or Ras guanine nucleotide-releasing protein 4, is a protein involved in the regulation of intracellular signaling pathways, particularly those related to the Ras family of small GTPases. The term RasGRP4 inhibitors refers to a group of molecules designed to selectively target and modulate the activity of RasGRP4. These inhibitors are primarily utilized as valuable tools in laboratory settings to investigate the intricate molecular functions and cellular processes associated with RasGRP4.

RasGRP4 inhibitors typically function by interfering with the RasGRP4 protein's activity, either by directly binding to it or disrupting its interactions with other cellular components. This interference can result in the modulation of intracellular signaling cascades and cellular processes influenced by RasGRP4, affecting various aspects of cellular function. Researchers employ RasGRP4 inhibitors to gain insights into the physiological roles and molecular interactions of RasGRP4 within cells, aiming to deepen our understanding of the fundamental cellular processes and mechanisms in which RasGRP4 is involved. Through the study of RasGRP4 inhibitors, scientists aim to unravel the complexities of intracellular signaling networks and uncover novel insights into the biology of RasGRP4, its potential roles in cellular homeostasis, and its broader implications in cellular function and regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can lead to the accumulation of misfolded proteins, potentially affecting the expression of proteins including RasGRP4.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

As a kinase inhibitor, it may affect signal transduction pathways and potentially downregulate RasGRP4 expression.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

An Hsp90 inhibitor that can destabilize client proteins and might affect the stability and expression of RasGRP4.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can alter downstream signaling pathways, potentially reducing RasGRP4 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor that might modulate transcription factor activity affecting RasGRP4 gene expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor that could influence the expression of various genes, including potentially that of RasGRP4.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting mTOR, it can suppress cellular growth and proliferation signals, possibly impacting RasGRP4 expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An inhibitor of MEK, which could thereby affect ERK pathway signaling and RasGRP4 expression.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

A PKC inhibitor that could disrupt signal transduction and potentially lower RasGRP4 expression.

WZ4003

1214265-58-3sc-473979
5 mg
$300.00
(0)

An inhibitor of NUAK kinases that may influence signaling pathways, potentially affecting the expression of RasGRP4.